Not so hypothetical.
Does anyone else feel like they’re back in a college ethics course debating which populations should be prioritized to receive a limited number of novel vaccines during a lethal pandemic..? For the bleeding hearts who want to allocate depending on vulnerability, this massive analysis of electronic medical records suggests those with current or recent cancer should be at the top of list. Higher rates of hospitalization (47%) and mortality (15%) were observed in those with both COVID-19 and a diagnosis of any cancer within the last year than with either diagnosis alone, with even worse stats for heme and lung cancers. | Wang, JAMA Oncol 2020